Literature DB >> 17925890

The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.

Bing Gong1, Elena Leznik.   

Abstract

Impairment of the ubiquitin-proteasome system (UPS) results in the failure to remove and degrade misfolded proteins and consequently causes the accumulation of misfolded proteins in the cell. The aberrant interactions between misfolded proteins and normal intracellular proteins are thought to underlie the pathogenesis in many neurodegenerative diseases. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is an important component of the UPS. Its major function is related to mono-ubiquitin recycling and thereby, sustaining protein degradation. Mutations of the UCH-L1 gene and alterations of its proteins' activity have been found to associate with several neurodegenerative disorders. In this review, we will discuss a link between UCH-L1 and Parkinson's, Huntington's and Alzheimer's diseases. We will also present a potential strategy for the treatment of Alzheimer's disease by boosting endogenous UCH-L1 activity. (c) 2007 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925890     DOI: 10.1358/dnp.2007.20.6.1138160

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  41 in total

1.  Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.

Authors:  Stefania Mondello; Andreas Jeromin; Andras Buki; Ross Bullock; Endre Czeiter; Noemi Kovacs; Pal Barzo; Kara Schmid; Frank Tortella; Kevin K Wang; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

Review 2.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

3.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

4.  LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Authors:  Dan Hu; Jian-Yi Niu; Jing Xiong; Shu-Ke Nie; Fei Zeng; Zhao-Hui Zhang
Journal:  Curr Med Sci       Date:  2018-12-07

5.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

6.  Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

Authors:  Stefania Mondello; Akinyi Linnet; Andras Buki; Steven Robicsek; Andrea Gabrielli; Joseph Tepas; Linda Papa; Gretchen M Brophy; Frank Tortella; Ronald L Hayes; Kevin K Wang
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

Review 7.  Potential Blood-based Biomarkers for Concussion.

Authors:  Linda Papa
Journal:  Sports Med Arthrosc Rev       Date:  2016-09       Impact factor: 1.985

8.  Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex.

Authors:  Anatoly Uzdensky; Svetlana Demyanenko; Grigory Fedorenko; Tayana Lapteva; Alexej Fedorenko
Journal:  Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.590

9.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

Review 10.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.